Liesl M. Hand, PA

Liesl Hand practices at Rochester Colon and Rectal Surgeons in Rochester, New York.

Liesl Hand's NPI, 1346351210, was assigned on August 31, 2006. Liesl Hand holds New York license 008321.

Liesl Hand's primary practice is Rochester Colon and Rectal Surgeons, at 121 Erie Canal Dr, Rochester, NY 14626 in Monroe County. The practice phone is (585) 222-6566.

Liesl Hand's primary practice is Rochester Colon and Rectal Surgeons in Rochester, New York. Liesl Hand is also affiliated with Rochester General Hospital. The medical group on file is Rochester Colon & Rectal Surgeons, P.C. Dmand AI also links Liesl Hand to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Liesl Hand practices, 2 sites in all. Vendor and product names are available with a free account.

Surgical is Liesl Hand's primary specialty in the NPI Registry, under taxonomy code 363AS0400X. Liesl Hand is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Liesl Hand is licensed in New York.

Dmand AI lists cold sores or genital herpes, hemorrhoids and itchy rashes among the conditions Liesl Hand treats.

CMS data shows 78 Medicare services from Liesl Hand across 3 procedure codes in 2024, for 84 Medicare patients. Medicare paid $5,892 for them. Every service was in an office.

CMS counts 84 Medicare patients who saw Liesl Hand in 2024. The largest group is 65 to 74, with 28 patients. 71% of them have high cholesterol, and 58% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Liesl Hand's median patient age at 69, with 56% women.

In 2024, Liesl Hand wrote 45 Medicare Part D claims for 27 patients. 98% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $449 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Liesl Hand for performance year 2024, reported as part of a group. Liesl Hand accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Liesl Hand from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Myriad Genetic Laboratories, Inc. paid the most, $187.